FMS earnings call for the period ending December 31, 2018.
News & Analysis: Fresenius Medical Care
Investors sold the stock off in response to surprisingly weak third-quarter results.
Find out which of these companies reacted to a big day in Canada.
Shares tumble after management dials back guidance. Here's what investors need to know.
Which stock wins in a one-on-one matchup between these two partners?
Investors received new details explaining why Fresenius dropped its acquisition. They aren't good.
The drama continues.
The dialysis services company continues to see its Kidney Care investment offset any potential net income elsewhere.
The dialysis services company got closer to breakeven earnings and boosted its guidance on strong sales growth.
Three Motley Fool analysts pick the company they'd most like to see in Buffett's portfolio again this holiday season.